A risk model that combines a mammographic artificial intelligence (AI) risk score with polygenic and clinical risk scores ...
An image-only artificial intelligence (AI) model recently authorized by the FDA conferred more precise risk stratification in predicting the 5-year risk of breast cancer compared with ...
Genetic risk models, including PREMMplus and BOADICEA/CanRisk, refine breast cancer risk assessment by incorporating genetic status and polygenic risk scores. Challenges in classifying gene variants, ...